275 related articles for article (PubMed ID: 30632416)
1. Pharmacokinetics and pharmacodynamics of monoclonal antibodies for asthma treatment.
Bagnasco D; Heffler E; Testino E; Passalacqua G; Canonica GW
Expert Opin Drug Metab Toxicol; 2019 Feb; 15(2):113-120. PubMed ID: 30632416
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic/pharmacodynamic profile of reslizumab in asthma.
Matera MG; Rogliani P; Calzetta L; Cazzola M
Expert Opin Drug Metab Toxicol; 2018 Feb; 14(2):239-245. PubMed ID: 29268638
[TBL] [Abstract][Full Text] [Related]
3. Anti-IgE and other antibody targets in asthma.
Singh J; Kraft M
Handb Exp Pharmacol; 2008; (181):257-88. PubMed ID: 18071950
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal Antibodies for the Management of Severe Asthma.
Rubinsztajn R; Chazan R
Adv Exp Med Biol; 2016; 935():35-42. PubMed ID: 27334730
[TBL] [Abstract][Full Text] [Related]
5. Targeted anti-IL-13 therapies in asthma: current data and future perspectives.
Ntontsi P; Papathanassiou E; Loukides S; Bakakos P; Hillas G
Expert Opin Investig Drugs; 2018 Feb; 27(2):179-186. PubMed ID: 29334288
[TBL] [Abstract][Full Text] [Related]
6. Molecular Targets for Biological Therapies of Severe Asthma.
Pelaia C; Crimi C; Vatrella A; Tinello C; Terracciano R; Pelaia G
Front Immunol; 2020; 11():603312. PubMed ID: 33329598
[TBL] [Abstract][Full Text] [Related]
7. dIvergEnt: How IgE Axis Contributes to the Continuum of Allergic Asthma and Anti-IgE Therapies.
Palomares Ó; Sánchez-Ramón S; Dávila I; Prieto L; Pérez de Llano L; Lleonart M; Domingo C; Nieto A
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28635659
[TBL] [Abstract][Full Text] [Related]
8. The role of monoclonal antibodies in the treatment of severe asthma.
Tourangeau LM; Kavanaugh A; Wasserman SI
Ther Adv Respir Dis; 2011 Jun; 5(3):183-94. PubMed ID: 21393345
[TBL] [Abstract][Full Text] [Related]
9. Targeting interleukins to treat severe asthma.
Gibeon D; Menzies-Gow AN
Expert Rev Respir Med; 2012 Aug; 6(4):423-39. PubMed ID: 22971067
[TBL] [Abstract][Full Text] [Related]
10. Dupilumab for the treatment of asthma.
Santini G; Mores N; Malerba M; Mondino C; Anzivino R; Macis G; Montuschi P
Expert Opin Investig Drugs; 2017 Mar; 26(3):357-366. PubMed ID: 28085503
[TBL] [Abstract][Full Text] [Related]
11. Lebrikizumab for the treatment of asthma.
Antoniu SA
Expert Opin Investig Drugs; 2016 Oct; 25(10):1239-49. PubMed ID: 27554950
[TBL] [Abstract][Full Text] [Related]
12. [Omalizumab. A monoclonal antibody against IgE].
Hennemann A
Med Monatsschr Pharm; 2004 Dec; 27(12):404-7. PubMed ID: 15646688
[No Abstract] [Full Text] [Related]
13. [Omralizumab (Xolair) in severe persistent allergic asthma].
Schleich F; Manise M; Louis R
Rev Med Liege; 2009; 64(5-6):313-7. PubMed ID: 19642466
[TBL] [Abstract][Full Text] [Related]
14. A Critical Evaluation of Anti-IL-13 and Anti-IL-4 Strategies in Severe Asthma.
Bagnasco D; Ferrando M; Varricchi G; Passalacqua G; Canonica GW
Int Arch Allergy Immunol; 2016; 170(2):122-31. PubMed ID: 27637004
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody therapy for the treatment of asthma and chronic obstructive pulmonary disease with eosinophilic inflammation.
Nixon J; Newbold P; Mustelin T; Anderson GP; Kolbeck R
Pharmacol Ther; 2017 Jan; 169():57-77. PubMed ID: 27773786
[TBL] [Abstract][Full Text] [Related]
16. [Pratical aspects of anti-Ige therapy in severe allergic asthma].
Taramarcaz P; Hauser C; Rochat T
Rev Med Suisse; 2007 Apr; 3(108):1050-2, 1054-5. PubMed ID: 17552257
[TBL] [Abstract][Full Text] [Related]
17. Future biologic therapies in asthma.
Quirce S; Bobolea I; Domínguez-Ortega J; Barranco P
Arch Bronconeumol; 2014 Aug; 50(8):355-61. PubMed ID: 24685200
[TBL] [Abstract][Full Text] [Related]
18. Immunoglobulin E blockade in the treatment of asthma.
Kuhn R
Pharmacotherapy; 2007 Oct; 27(10):1412-24. PubMed ID: 17896896
[TBL] [Abstract][Full Text] [Related]
19. Anti-immunoglobulin E therapy with omalizumab for asthma.
Hendeles L; Sorkness CA
Ann Pharmacother; 2007 Sep; 41(9):1397-410. PubMed ID: 17698897
[TBL] [Abstract][Full Text] [Related]
20. Targeted therapeutics for severe refractory asthma: monoclonal antibodies.
Grainge CL; Maltby S; Gibson PG; Wark PA; McDonald VM
Expert Rev Clin Pharmacol; 2016 Jul; 9(7):927-41. PubMed ID: 27018798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
